NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of uniQure N.V. ("uniQure" or "the Company") (NASDAQ:QURE). Investors who purchased uniQure securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/QURE. Investigation […]

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AVITA Medical, Inc. ("AVITA" or "the Company") (NASDAQ:RCEL). Investors who purchased AVITA securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCEL.

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT). Investors who purchased Ultra Clean securities prior to May 6, 2024, and continue to hold to the

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a securities fraud class action lawsuit has been filed against Sina Corporation ("Sina" or the "Company") (formerly NASDAQ:SINA) and certain of its executive officers (collectively, "Defendants") on behalf of investors who sold Sina ordinary shares, including those that sold

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Six Flags Entertainment Corporation ("Six Flags" or the "Company") (NYSE:FUN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tvardi Therapeutics, Inc. ("Tvardi" or "the Company") (NASDAQ:TVRD). Investors who purchased Tvardi securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TVRD.

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities prior to February 18, 2021, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail